Search results for "Protection"

showing 10 items of 1623 documents

Beneficial effect of dipyridyl, a liposoluble iron chelator against focal cerebral ischemia: In vivo and in vitro evidence of protection of cerebral …

2007

Whereas iron chelators were shown to induce neuroprotection against brain injury, the effect of iron chelators on ischemia-induced damage of cerebral endothelium is largely unknown. Our objective was to explore the endothelioprotective effect of the lipophilic iron chelator dipyridyl (DP) (i) in vitro on the death of cerebral endothelial cells (CECs) subjected to intracellular iron loading and (ii) in vivo on the ischemia-induced blood-brain barrier (BBB) disruption. When given shortly after iron exposure or brain ischemia, DP prevented the death of CECs and diminished BBB disruption, respectively, whereas a delayed administration of DP was associated with a lower CECs protection. Interesti…

MaleProgrammed cell deathTime FactorsIronIschemiaPharmacologymedicine.disease_causeBlood–brain barrierIron Chelating AgentsTransfectionNeuroprotectionStatistics NonparametricBrain IschemiaBrain ischemiaMice22'-DipyridylIn vivoIschemiamedicineAnimalsPROTECTIONMolecular BiologyCells CulturedtherapyCell DeathDose-Response Relationship DrugChemistrySuperoxide DismutaseGeneral NeuroscienceLEDEndothelial CellsBrainProteinscellmedicine.diseaseEndothelial stem cellIn VitroDisease Models Animalmedicine.anatomical_structureGene Expression RegulationBlood-Brain BarrierBrain InjuriesImmunologyCELLScardiovascular systemNeurology (clinical)Oxidative stressHeme Oxygenase-1Developmental Biology
researchProduct

Urban green and grey space in relation to respiratory health in children

2017

We assessed the effect of three different indices of urban built environment on allergic and respiratory conditions.This study involved 2472 children participating in the ongoing INMA birth cohort located in two bio-geographic regions (Euro-Siberian and Mediterranean) in Spain. Residential surrounding built environment was characterised as 1) residential surrounding greenness based on satellite-derived normalised difference vegetation index (NDVI), 2) residential proximity to green spaces and 3) residential surrounding greyness based on urban land use patterns. Information on wheezing, bronchitis, asthma and allergic rhinitis up to age 4 years was obtained from parent-completed questionnair…

MaleRespiratory SystemViridiplantae010501 environmental sciencesForestsLogistic regression01 natural sciencesBIRTH COHORTS0302 clinical medicineEnvironmental protection030212 general & internal medicineBuilt environmentESTIMATING EQUATIONSChild HealthEnvironmental exposure11 Medical And Health SciencesHOUSE-DUSTSENSITIZATIONALLERGYChild PreschoolBronchitisFemaleBirth cohortRisk assessmentLife Sciences & BiomedicinePulmonary and Respiratory MedicineEnvironmentRisk AssessmentNormalized Difference Vegetation Index03 medical and health sciencesEARLY-LIFEEnvironmental healthmedicineHumansBronchitisENVIRONMENTAL BIODIVERSITYRespiratory health0105 earth and related environmental sciencesScience & Technologybusiness.industryUrban HealthCHILDHOOD ASTHMAAIR-POLLUTIONEnvironmental Exposuremedicine.diseaseRhinitis AllergicAsthmaSpainIMMUNE-SYSTEMbusiness
researchProduct

Statins, Fracture Risk, and Bone Remodeling: What Is True?

2006

Besides the action on plasma lipid levels, statins show a series of ancillary effects defined as all of their vascular and nonvascular effects independent from the cholesterol reduction. It has been recently hypothesized that one of these ancillary effects could be the improvement of bone health, due to the interference with bone metabolism. This may potentially represent the rationale for statins' use in the treatment of osteoporosis, the most common disease of the bone. Both experimental observations and clinical studies on this topic generated a number of conflicting results; however, the largest randomized clinical trials, the Scandinavian Simvastatin Survival Study (4S), Long Term Inte…

MaleRiskSimvastatinmedicine.medical_specialtyOsteoporosisMyocardial IschemiaBioinformaticsBone remodelinglaw.inventionFractures Bonechemistry.chemical_compoundRandomized controlled trialRisk FactorslawHumansMedicineLongitudinal StudiesRisk factorPravastatinRandomized Controlled Trials as Topicbusiness.industryCholesterolOsteoporosiStatinnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseSurgerychemistrySimvastatinOsteoporosisFemalelipids (amino acids peptides and proteins)Bone RemodelingTherapyHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessFracturesHeart Protection StudyPravastatinmedicine.drugThe American Journal of the Medical Sciences
researchProduct

Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease

2011

Mitochondrial dysfunction and oxidative stress occur in Parkinson’s disease (PD), but little is known about the molecular mechanisms controlling these events. Peroxisome proliferator-activated receptor-gamma coactivator-1α (PGC-1α) is a transcriptional coactivator that is a master regulator of oxidative stress and mitochondrial metabolism. We show here that transgenic mice overexpressing PGC-1α in dopaminergic neurons are resistant against cell degeneration induced by the neurotoxin MPTP. The increase in neuronal viability was accompanied by elevated levels of mitochondrial antioxidants SOD2 and Trx2 in the substantia nigra of transgenic mice. PGC-1α overexpression also protected against MP…

MaleSOD2Mice TransgenicSubstantia nigraMitochondrionBiologyNeuroprotectionCell LineMiceCellular and Molecular Neurosciencechemistry.chemical_compoundDopaminemedicineAnimalsNeurotoxinParkinson Disease SecondaryMolecular BiologyPGC-1α RSV SIRT1 MPTP Dopaminergic neurons Parkinson’s diseasePharmacologyMPTPDopaminergicBrainParkinson DiseaseCell BiologyPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaMitochondriaCell biologyDisease Models AnimalOxidative Stressnervous systemBiochemistrychemistry1-Methyl-4-phenyl-1236-tetrahydropyridineTrans-ActivatorsMolecular MedicineFemaleTranscription Factorsmedicine.drugCellular and Molecular Life Sciences
researchProduct

Protective role of the Mediterranean diet on several cardiovascular risk factors: Evidence from Sicily, southern Italy

2014

Background and aims: Epidemiological studies conducted in European countries demonstrated that the adoption of a Mediterranean diet protect against clustered risk factors but those evaluating such benefits specifically in southern Italy are scarce. Thus, the aim of this study was to assess the association between the adherence to the Mediterranean diet and cardiovascular risk factors obesity, diabetes, and hypertension. Methods and results: A cross-sectional population-based survey including 3090 subjects was conducted in Sicily, southern Italy. Food intake was evaluated through a validated food frequency questionnaire and adherence to the dietary pattern was assessed using the MedDietScore…

MaleSettore MED/09 - Medicina InternaMediterranean dietHealth StatusEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Diet MediterraneanLogistic regressionSettore MED/13 - EndocrinologiaHealth StatuRisk FactorsEnvironmental protectionSurveys and QuestionnairesCardiovascular DiseaseEpidemiologyOdds RatioPrevalenceNutrition and DieteticSurveys and QuestionnaireSettore MED/49 - Scienze Tecniche Dietetiche ApplicateSicilyCardiovascular risk factorsBody mass indexeducation.field_of_studyNutrition and DieteticsMedicine (all)ConfoundingHealth SurveyMiddle AgedCardiovascular DiseasesHypertensionLinear ModelFemaleCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyLogistic ModelPopulationCardiovascular risk factorMediterranean dietmedicineHumansObesityeducationLife StyleAgedCross-Sectional Studiebusiness.industryRisk FactorOdds ratiomedicine.diseaseHealth SurveysObesityConfidence intervalCross-Sectional StudiesLogistic ModelsLinear ModelsPatient CompliancebusinessRisk Reduction BehaviorDemographyNutrition, Metabolism and Cardiovascular Diseases
researchProduct

PERIPHERAL SURFACE DOSE FROM A LINEAR ACCELERATOR: RADIOCHROMIC FILM EXPERIMENTAL MEASUREMENTS OF FLATTENING FILTER FREE VERSUS FLATTENED BEAMS

2020

Abstract There is a growing interest in the use of flattening filter free (FFF) beams due to the shorter treatment times. The reduction of head scatter suggests a better radiation protection to radiotherapy patients, considering the expected decrease in peripheral surface dose (PSD). In this work, PSD of flattened (FF) and FFF-photon beams was compared. A radiochromic film calibration method to reduce energy dependence was used. PSD was measured at distances from 2 to 50 cm to the field border for different square field sizes, modifying relevant clinical parameters. Also, clinical breast and prostate stereotactic body radiotherapy (SBRT) plans were studied. For square beams, FFF PSD is lowe…

MaleSurface (mathematics)Materials scienceRadiosurgerySquare (algebra)Linear particle accelerator030218 nuclear medicine & medical imaging03 medical and health sciencesRadiation Protection0302 clinical medicineOpticsCalibrationHumansRadiology Nuclear Medicine and imagingRadiochromic filmPhotonsRadiationFlattening filter freeRadiological and Ultrasound Technologybusiness.industryRadiotherapy Planning Computer-AssistedPublic Health Environmental and Occupational HealthRadiotherapy DosageGeneral MedicinePeripheral030220 oncology & carcinogenesisParticle AcceleratorsRadiation protectionbusinessRadiation Protection Dosimetry
researchProduct

Human Biomonitoring of food contaminants in Spanish children: Design, sampling and lessons learned

2017

Abstract Human Biomonitoring (HBM) studies are highly useful for evaluating population exposure to environmental contaminants and are being carried out in increasing numbers all over the world. The use of HBM in the field of food safety, in a risk assessment context, presents a growing interest as more health-based guidance values (HBGV) in biological matrices are derived, and can be used in a complementary way to the external exposure approaches such as total diet studies or surveillance programmes. The aims of the present work are: i) to describe the methodological framework of the BIOVAL study, a cross-sectional HBM program carried out by the Health Department of the Regional Government …

MaleTECNOLOGIA DE ALIMENTOSFood ContaminationContext (language use)010501 environmental sciencesUrine01 natural sciences03 medical and health sciences0302 clinical medicineEnvironmental protectionEnvironmental healthBiomonitoringHumans030212 general & internal medicineChildFieldworkChildren0105 earth and related environmental sciencesFood contaminantsGovernmentbusiness.industryPublic Health Environmental and Occupational HealthStudy designFood safetyHuman biomonitoringGeographyWork (electrical)SpainPopulation studyEnvironmental PollutantsFemaleRisk assessmentbusinessEnvironmental MonitoringHealth departmentHair
researchProduct

Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

2007

A large body of evidence indicates that the hormone erythropoietin (EPO) exerts beneficial effects in the central nervous system (CNS). To date, EPO's effect has been assessed in several experimental models of brain and spinal cord injury. This study was conducted to validate whether treatment with recombinant human EPO (rHuEPO) would limit the extent of injury following experimental TBI. Experimental TBI was induced in rats by a cryogenic injury model. rHuEPO or placebo was injected intraperitoneally immediately after the injury and then every 8 h until 2 or 14 days. Forty-eight hours after injury brain water content, an indicator of brain edema, was measured with the wet-dry method and bl…

MaleTime FactorsBrain EdemaFunctional LateralityRats Sprague-Dawleychemistry.chemical_compoundTraumatic brain injuryMedicineAnalysis of Variance Animals Blood-Brain Barrier; drug effects Brain Edema; drug therapy/etiology Brain Infarction; drug therapy/etiology Brain Injuries; complications/drug therapy Disease Models; Animal Erythropoietin; administration /&/ dosage Evans Blue; diagnostic use Functional Laterality Humans Male Neurologic Examination Neuroprotective Agents; administration /&/ dosage Rats Rats; Sprague-Dawley Reaction Time; drug effects Recombinant Proteins Time Factorsadministration /&/ dosageSpinal cord injuryEvans BlueNeurologic ExaminationGeneral Neuroscienceexperimental models of brain and spinal cord injuryExtravasationNeuroprotectionRecombinant Proteinsmedicine.anatomical_structureNeuroprotective AgentsBlood-Brain BarrierAnesthesiadiagnostic usemedicine.drugEvans BlueBrain InfarctionTraumatic brain injuryCentral nervous systemrecombinant human EPO (rHuEPO)PlaceboNeuroprotectionReaction TimeAnimalsHumansMolecular BiologyErythropoietinAnalysis of VarianceNeuroscience (all)business.industryAnimaldrug therapy/etiologymedicine.diseaseRatsDisease Models AnimalchemistryErythropoietindrug effectsBrain InjuriesDisease Modelsrecombinant human EPO (rHuEPO); experimental models of brain and spinal cord injury; NeuroprotectionNeurology (clinical)Sprague-Dawleybusinesscomplications/drug therapyDevelopmental BiologyBrain research
researchProduct

Neuroprotective potential of erythropoietin and darbepoetin alfa in an experimental model of sciatic nerve injury. Laboratory investigation.

2007

Object The objectives of this study were to examine whether the systemic administration of recombinant human erythropoietin (rHuEPO) and its long-lasting derivative darbepoetin alfa expedited functional recovery in a rat model of sciatic nerve injury, and to compare the effects of these agents in the model. Methods Thirty male Sprague–Dawley rats received a crush injury to the left sciatic nerve and subsequently underwent either placebo treatment, daily injections of rHuEPO, or weekly injections of darbepoetin alfa. Results Both rHuEPO and darbepoetin alfa were effective in reducing neurological impairment and improving compound muscle action potentials following nerve injury. Darbepoetin …

MaleTime FactorsDarbepoetin alfaNerve CrushAction PotentialsPlaceboDrug Administration ScheduleRats Sprague-Dawleyadministration /&/ dosage/pharmacologymedicineAnimalsHumansDarbepoetin alfaMuscle SkeletalErythropoietinERYTHROPOIETINdrug effects/injuries/physiopathologySettore MED/27 - Neurochirurgiabusiness.industryAction Potentials; drug effects Animals Drug Administration Schedule Erythropoietin; administration /&/ dosage/analogs /&/ derivatives/pharmacology Humans Male Muscle; Skeletal; physiopathology Nerve Crush Neuroprotective Agents; administration /&/ dosage/pharmacology Rats Rats; Sprague-Dawley Recombinant Proteins Recovery of Function; drug effects Sciatic Nerve; drug effects/injuries/physiopathology Time FactorsGeneral MedicineSkeletalRecovery of FunctionNerve injurySciatic nerve injurymedicine.diseaseadministration /&/ dosage/analogs /&/ derivatives/pharmacologySciatic NerveNeuroprotectionRecombinant ProteinsRatsNeuroprotective AgentsNeurologyErythropoietinPeripheral nerve injuryAnesthesiadrug effectsPeripheral nerve injuryCrush injuryMuscleSurgeryNeurology (clinical)Sciatic nerveSprague-Dawleymedicine.symptomphysiopathologybusinessmedicine.drug
researchProduct

2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice

2014

HIF-1α is pivotal for cellular homeostasis in response to cerebral ischemia. Pharmacological inhibition of HIF-1α may reduce secondary brain damage by targeting post-translational mechanisms associated with its proteasomal degradation and nuclear translocation. This study examined the neuroprotective effects of 2-methoxyestradiol (2ME2), the involved HIF-1α-dependent response, and alternative splicing in exon 14 of HIF-1α (HIF-1α∆Ex14) after traumatic brain injury (TBI) in mice. Intraperitoneal 2ME2 administration 30 min after TBI caused a dose-dependent reduction in secondary brain damage after 24 h. 2ME2 was physiologically tolerated, showed no effects on immune cell brain migration, and …

MaleTraumatic brain injuryBlotting WesternIschemiaCellular homeostasisBrain damagePharmacologyBiologyBiochemistryNeuroprotectionBrain IschemiaMitochondrial ProteinsMiceCellular and Molecular Neurosciencechemistry.chemical_compoundPlasminogen Activator Inhibitor 1medicineAnimalsCell NucleusNeuronsEstradiolTumor Necrosis Factor-alphaAlternative splicingMembrane ProteinsExonsHypoxia-Inducible Factor 1 alpha Subunitmedicine.diseaseImmunohistochemistryUp-RegulationMice Inbred C57BLAlternative SplicingProtein TransportNeuroprotective AgentsGene Expression RegulationchemistryBrain InjuriesPlasminogen activator inhibitor-1Tumor necrosis factor alphamedicine.symptomNeuroscienceInjections IntraperitonealSubcellular FractionsJournal of Neurochemistry
researchProduct